COPD Trial, Recruiting (NCT04252781)

COPD Trial, Recruiting NCT04252781 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT04252781 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Initial screening phase (Phase I):

People who are over 35 years old
People who have smoked more than 20 pack-years (a measure of long-term smoking history — confirm with trial site if unsure how this is calculated)
People who are currently smoking, or who stopped smoking less than 1 month ago
People who have signed consent to take part in Phase I of the study

Second phase (Phase II — for people found to have COPD during screening):

People whose breathing test results show a specific pattern that indicates COPD (a reduced airflow ratio known as FEV1/FVC below 70% of the expected value or below the lower limit of normal)
People who have signed consent to take part in Phase II of the study

Who may not be able to join:

People who have already been diagnosed with COPD before the study
People who are currently receiving treatment for cancer
People who are not enrolled in a French social security or social protection scheme
People who are pregnant or breastfeeding
People who are in legal custody or under a legal guardianship arrangement

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Laurent BOYER, MD, Assistance Publique Hôpitaux de Paris (AP-HP)

Phone: (0) 1 49 81 26 90

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04252781

Sponsor: Assistance Publique - Hôpitaux de Paris

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: (0) 1 49 81 26 90

More information: https://clinicaltrials.gov/study/NCT04252781

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Initial screening phase (Phase I):

People who are over 35 years old
People who have smoked more than 20 pack-years (a measure of long-term smoking history — confirm with trial site if unsure how this is calculated)
People who are currently smoking, or who stopped smoking less than 1 month ago
People who have signed consent to take part in Phase I of the study

Second phase (Phase II — for people found to have COPD during screening):

People whose breathing test results show a specific pattern that indicates COPD (a reduced airflow ratio known as FEV1/FVC below 70% of the expected value or below the lower limit of normal)
People who have signed consent to take part in Phase II of the study

Who may not be able to join:

People who have already been diagnosed with COPD before the study
People who are currently receiving treatment for cancer
People who are not enrolled in a French social security or social protection scheme
People who are pregnant or breastfeeding
People who are in legal custody or under a legal guardianship arrangement

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique - Hôpitaux de Paris

Registry

ClinicalTrials.gov

Start date

20 August 2020

Est. completion

7 January 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

1-year adverse evolution

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov